Showing results (571-580 of 604) with videos related to
Sort By:
Pageof 61
British Journal of Anaesthesia|October 8, 2019
Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendationsChristopher C Young, Erica M Harris, Charles Vacchiano, et al.Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Altered fear learning across development in both mouse and humanSiobhan S Pattwell, Stéphanie Duhoux, Catherine A Hartley, et al.Proceedings of the National Academy of Sciences of the United States of America|April 30, 2020
Inhibition of sphingolipid synthesis improves outcomes and survival in GARP mutant wobbler mice, a model of motor neuron degenerationConstance S Petit, Jane J Lee, Sebastian Boland, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2018
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF studyMelissa E Middeldorp, Rajeev K Pathak, Megan Meredith, et al.Pilot and Feasibility Studies|December 4, 2018
Correction to: The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonistsQinghua Meng, Baowei Zhao, Qiongfeng Xu, et al.International Journal of Cardiology|July 31, 2018
Diagnostic accuracy of overnight oximetry for the diagnosis of sleep-disordered breathing in atrial fibrillation patientsDominik Linz, Kadhim Kadhim, Anthony G Brooks, et al.Bioorganic & Medicinal Chemistry|September 24, 2013
Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitorsGuanghui Deng, Baowei Zhao, Yingli Ma, et al.Pilot and Feasibility Studies|November 22, 2018
The help for people with money, employment or housing problems (HOPE) intervention: pilot randomised trial with mixed methods feasibility researchM C Barnes, A M Haase, L J Scott, et al.Journal of Medicinal Chemistry|March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptorKatherine L Widdowson, John D Elliott, Daniel F Veber, et al.Pageof 61